High Incidence of Sepsis due to Increasing Nosocomial Infections Fuels South & Central America Sepsis Diagnostics Market Growth
Infection is the root cause of sepsis. Sepsis mainly occurs in immunocompromised people, such as those taking chemotherapy, having a splenectomy, and suffering from AIDS and chronic illnesses like diabetes. Among several types of infections, nosocomial infections are the primary cause of morbidity and mortality among hospitalized patients. Most deaths can be prevented through early diagnosis and appropriate clinical management. These deaths are often a consequence of diarrheal diseases or lower respiratory infections. Thus, the high incidence rate of sepsis is expected to boost the demand for sepsis diagnostic products, thereby supporting the South & Central America sepsis diagnostics market growth during the forecast period.
South & Central America Sepsis Diagnostics Market Overview
The South & Central America sepsis diagnostics market is segmented into Argentina, Brazil, and the Rest of South & Central America. The market growth in the region is attributed to the rising aging population and increasing burden of sepsis cases in the region.
South & Central America Sepsis Diagnostics Market Segmentation
The South & Central America sepsis diagnostics market is segmented on the basis of product, technology, method, test type, pathogen, end user, and country.
Based on product, the South & Central America sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. The blood culture media segment held the largest market share in 2021.
Based on technology, the South & Central America sepsis diagnostics market is segmented into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment held the largest market share in 2021. The market for the molecular diagnostics segment is sub segmented into polymerase chain reaction, peptide nucleic acid-fluorescent in situ hybridization, syndromic panel-based testing, and microarrays.
Based on method, the South & Central America sepsis diagnostics market is bifurcated into automated diagnostics and conventional diagnostics. The conventional diagnostics segment held a larger market share in 2021.
Based on test type, the South & Central America sepsis diagnostics market is bifurcated into point-of-care tests and laboratory tests. The laboratory tests segment held a larger market share in 2021.
Based on pathogen, the South & Central America sepsis diagnostics market is segmented into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment held the largest market share in 2021.
Based on end user, the South & Central America sepsis diagnostics market is segmented into hospitals, pathology and reference laboratories, and others. The hospitals segment held the largest market share in 2021.
Based on country, the South & Central America sepsis diagnostics market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the market share in 2021.
Abbott; BD; bioMerieux SA; Danaher (Beckman Coulter); F. HOFFMANN-LA ROCHE LTD.; and THERMO FISHER SCIENTIFIC INC. are among the leading companies operating in the South & Central America sepsis diagnostics market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 38.66 Million |
| Market Size by 2028 | US$ 69.59 Million |
| CAGR (2021 - 2028) | 8.8% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
The South & Central America Sepsis Diagnostics Market is valued at US$ 38.66 Million in 2021, it is projected to reach US$ 69.59 Million by 2028.
As per our report South & Central America Sepsis Diagnostics Market, the market size is valued at US$ 38.66 Million in 2021, projecting it to reach US$ 69.59 Million by 2028. This translates to a CAGR of approximately 8.8% during the forecast period.
The South & Central America Sepsis Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Sepsis Diagnostics Market report:
The South & Central America Sepsis Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Sepsis Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Sepsis Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South & Central America Sepsis Diagnostics Market
